News | November 12, 2021
Natco Pharma PAT at Rs 65.1 cr. in Q2FY22
Natco Pharma has reported consolidated financial results for the period ended September 30, 2021
Natco Pharma has reported consolidated financial results for the period ended September 30, 2021
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
The company will provide the technical and financial resources to support the study
The consideration for the acquisition is US $ 2.25 million
Sudeep Nutrition will be a one-stop solution for food, beverage, nutraceuticals and nutritional product manufacturers
Evidence also shows better immune response to virus among users of spray
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
Shaan’s hit song `Tanha Dil Tanha Safar relaunched
Subscribe To Our Newsletter & Stay Updated
